Dexecadotril
Symptomatic treatment of acute diarrhea
- CAS No.
- 112573-72-5
- Indication Class
- Gastroenterology / Hepatology
- Patent Expiry
- Off-patent · 2015 (indicative)
- Therapeutic Area
- Gastroenterology
- Labeled Purity
- 98%+
- Registration Readiness
- GMP/DMF
- Commercialization Tier
- API (Commercialized)
- Linked Intermediates
- Confirm per inquiry
- Patent Scope
- Cadotril-class older product; compound patent expired
Key Intermediates for This API
Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higherNo intermediate entries are on file for this API yet. You can still enquire by CAS number — we will route it to the supply side for manual sourcing.
Listing Logic · Why It's Worth Listing
An anti-secretory antidiarrheal that does not inhibit intestinal motility and pairs with rehydration, widely used in pediatric acute diarrhea.
Gastroenterology · Marketed; available for immediate sourcing
GMP/DMF-ready; supports regulatory filing and audit in target markets
Intermediates confirmed per inquiry
Product Description
Dexecadotril is an antidiarrheal drug that reduces intestinal secretion by enhancing endogenous enkephalin activity, and belongs to a novel anti secretion antidiarrheal mechanism that does not inhibit intestinal motility.
Supply source: Unibest · Dexecadotril, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.